Results 61 to 70 of about 367 (113)

Compassionate use of contezolid in a toddler with severe community-acquired pneumonia induced by staphylococcus aureus: a case report and follow-up

Frontiers in Pediatrics
BackgroundInitial choices of antimicrobial therapy for most cases of community-acquired pneumonia (CAP) in children under 5 years of age are typically based on local epidemiology, risk factors assessment, and subsequent clinical parameters and positive ...
Hui-Ying Liu, Xiao-Fei Bi, Ya-Jun Wang, Feng-Jie Xie, Hong Zhang, Yu-Cheng Zhu, Yan Zhang, Zhi-Hui Wang, Di Wu, Huan Meng, Yi-Lu Lin, Lin-Qiong Liu, Shu-Xiao Qiu, Yan Gao, Kai Kang, Yang Gao   +15 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Image2_Compassionate use of contezolid in a toddler with severe community-acquired pneumonia induced by staphylococcus aureus: a case report and follow-up.tif

BackgroundInitial choices of antimicrobial therapy for most cases of community-acquired pneumonia (CAP) in children under 5 years of age are typically based on local epidemiology, risk factors assessment, and subsequent clinical parameters and positive ...
Yan Gao (93649), Kai Kang (195645), Yu-Cheng Zhu (9676980), Ya-Jun Wang (137203), Huan Meng (231636), Hong Zhang (25820), Shu-Xiao Qiu (17915345), Xiao-Fei Bi (17915333), Yi-Lu Lin (17915339), Feng-Jie Xie (17915336), Hui-Ying Liu (10193468), Yan Zhang (8098), Lin-Qiong Liu (17915342), Zhi-Hui Wang (700100), Di Wu (23906), Yang Gao (18005)   +15 more
core   +1 more source

Image1_Compassionate use of contezolid in a toddler with severe community-acquired pneumonia induced by staphylococcus aureus: a case report and follow-up.tif

BackgroundInitial choices of antimicrobial therapy for most cases of community-acquired pneumonia (CAP) in children under 5 years of age are typically based on local epidemiology, risk factors assessment, and subsequent clinical parameters and positive ...
Yan Gao (93649), Kai Kang (195645), Yu-Cheng Zhu (9676980), Ya-Jun Wang (137203), Huan Meng (231636), Hong Zhang (25820), Shu-Xiao Qiu (17915345), Xiao-Fei Bi (17915333), Yi-Lu Lin (17915339), Feng-Jie Xie (17915336), Hui-Ying Liu (10193468), Yan Zhang (8098), Lin-Qiong Liu (17915342), Zhi-Hui Wang (700100), Di Wu (23906), Yang Gao (18005)   +15 more
core   +1 more source

Synergistic activity of fosfomycin combined with old and new oxazolidinones (linezolid, contezolid, delpazolid, and sutezolid) against bloodstream isolates of vancomycin-resistant Enterococcus faecium

Purpose: Current treatment options for infections caused by vancomycin-resistant (VR) Enterococcus faecium remain limited and often suboptimal. This study investigates the in vitro activity of combination therapies involving fosfomycin and oxazolidinones
Zerbato, Verena, Toc, Dan Alexandru, Lagatolla, Cristina, Di Bella, Stefano   +3 more
core   +1 more source

New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?

Multidrug-resistant tuberculosis (MDR-TB) is a global health concern. Standard treatment involves the use of linezolid, a repurposed oxazolidinone. It is associated with severe adverse effects, including myelosuppression and mitochondrial toxicity.
Davies, Forsman L,, Alffenaar, J-W, Burke, A, Chen, RH, Cho, J-G   +4 more
core   +2 more sources

Case Report: Contezolid-containing regimens for disseminated Bacillus Calmette–Guérin disease in three children with primary immunodeficiency

Frontiers in Pediatrics
IntroductionDisseminated Bacillus Calmette–Guérin (BCG) disease is a rare but life-threatening complication in children with primary immunodeficiency (PID). Linezolid (LZD) is effective but limited by myelosuppression.
Zhen Zhang, Junchi Xu, Li Gao, Junjia Liu, Zhijian Ye, Yong Xu, Jianping Zhang, Xin Yu   +7 more
doaj   +1 more source

Current Advances in Developing New Antimicrobial Agents Against Non-Tuberculous Mycobacterium

Non-tuberculous mycobacteria (NTM) comprise more than 190 species capable of causing severe pulmonary, lymphatic, cutaneous, and disseminated infections, particularly in immunocompromised populations.
Rahman, Khondaker Miraz, Khondaker Miraz Rahman, Cross, Jane, Nupur Gargate, Gargate, Nupur, Jane Cross   +5 more
core   +1 more source

Comparative In Vitro Drug Susceptibility Study of Five Oxazolidinones Against Mycobacterium tuberculosis in Hainan, China

Oxazolidinones, novel synthetic antibacterials, inhibit protein biosynthesis and show potent activity against Gram-positive bacteria, including Mycobacterium tuberculosis (MTB).
Jinhui Dong, Meiping Lv, Ming Luo, Peibo Li, Jieying Wang, Hua Pei, Qian Cheng, Yeteng Zhong, Zhuolin Chen, Chuanning Tang   +9 more
core   +1 more source

Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity

, 2021
Kate M. Voss, Jinqian Liu, Mikhail F. Gordeev, Wen Wang   +3 more
core   +1 more source